Polyamines in eukaryotes, bacteria, and archaea

AJ Michael - Journal of Biological Chemistry, 2016 - jbc.org
Polyamines are primordial polycations found in most cells and perform different functions in
different organisms. Although polyamines are mainly known for their essential roles in cell …

Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis

AS Nagle, S Khare, AB Kumar, F Supek… - Chemical …, 2014 - ACS Publications
Leishmaniasis is a parasitic disease that presents four main clinical syndromes: cutaneous
leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), visceral leishmaniasis/kala azar …

Recent updates and perspectives on leishmaniasis

D Savoia - The Journal of Infection in Develo** Countries, 2015 - jidc.org
Leishmaniasis is a neglected vector-borne tropical infection considered to be a disease of
the poor. Concentrated in poverty-stricken countries within Southeast Asia, East Africa, and …

[HTML][HTML] Macrophages as host, effector and immunoregulatory cells in leishmaniasis: Impact of tissue micro-environment and metabolism

C Bogdan - Cytokine: X, 2020 - Elsevier
Leishmania are protozoan parasites that predominantly reside in myeloid cells within their
mammalian hosts. Monocytes and macrophages play a central role in the pathogenesis of …

A review on potential therapeutic targets for the treatment of leishmaniasis

SY Sheikh, F Hassan, D Shukla, S Bala, T Faruqui… - Parasitology …, 2024 - Elsevier
Leishmania, a protozoan parasite, is responsible for the occurrence of leishmaniasis, a
disease that is prevalent in tropical regions. Visceral Leishmaniasis (VL), also known as kala …

Amino acids as mediators of metabolic cross talk between host and pathogen

W Ren, R Rajendran, Y Zhao, B Tan, G Wu… - Frontiers in …, 2018 - frontiersin.org
The interaction between host and pathogen decidedly shapes the outcome of an infection,
thus understanding this interaction is critical to the treatment of a pathogen-induced …

[HTML][HTML] The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase

ER da Silva, C do Carmo Maquiaveli… - Experimental …, 2012 - Elsevier
Polyamine biosynthesis enzymes are promising drug targets for the treatment of
leishmaniasis, Chagas' disease and African slee** sickness. Arginase, which is a …

A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin …

A Ilari, P Baiocco, L Messori, A Fiorillo, A Boffi… - Amino acids, 2012 - Springer
Auranofin is a gold (I)-containing drug in clinical use as an antiarthritic agent. Recent studies
showed that auranofin manifests interesting antiparasitic actions very likely arising from …

Leishmania Hijacks Myeloid Cells for Immune Escape

M Martínez-López, M Soto, S Iborra… - Frontiers in …, 2018 - frontiersin.org
Protozoan parasites of the Leishmania genus are the causative agents of leishmaniasis, a
group of neglected tropical diseases whose clinical manifestations vary depending on the …

TNF-mediated restriction of arginase 1 expression in myeloid cells triggers type 2 NO synthase activity at the site of infection

U Schleicher, K Paduch, A Debus, S Obermeyer… - Cell reports, 2016 - cell.com
Neutralization or deletion of tumor necrosis factor (TNF) causes loss of control of intracellular
pathogens in mice and humans, but the underlying mechanisms are incompletely …